ISRCTN71715857已完成未知
EUROACTION - A European wide effort to raise the standards of preventive cardiology
European Society of Cardiology (France)0 个研究点目标入组 10,000 人开始时间: 2006年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18555911 results 2012 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/23065443 cost-effectiveness 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35362378/ (added 04/04/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Hospital arm:
- •1. In- and out-hospital patients who meet the inclusion criteria and who agree to participate in the trial. Within each hospital (both intervention and usual care) all consecutive new patients with medical diagnosis of Coronary Heart Disease (CHD) (see below), men and women under 80 years of age, will be identified:
- •1.1. Acute coronary syndromes, unstable angina, non Q wave Myocardial Infarction (MI), Q wave MIb
- •1.2. Stable angina pectoris
- •2. Partners of patients living in the same household
- •3. First degree blood relatives of patients with premature CHD
- •Primary Care arm:
- •1. High risk individuals who meet the following inclusion criteria and who agree to participate in the trial. Men and women, 50 years of age or older, but less than 80 years, without history of coronary heart disease were identified in three categories as follows:
- •1.1. High multifactorial risk individuals: CVD risk more than or equal to 5% over ten years (now or projected to age 60 years), according to the HeartScore risk estimation system
- •1.2. Antihypertensive and/or lipid-lowering therapies initiated in the last year
- •1.3. New or known diabetes diagnosed in the last three years
- •2. Partners of high-risk individuals living in the same household
排除标准
- •Hospital arm:
- •1. Aged 80 years of age or older
- •2. Severe heart failure
- •3. Impaired cognitive function
- •4. Severe physical disability
- •Primary Care arm:
- •1. Under 50 and over 80 years of age
- •2. Mentally or physically incapable
研究者
相似试验
进行中（未招募）
1 期
EUROACTION PLUS con intervención intensiva sobre el tabaco (vareniclina) durante un programa de cardiología preventiva para pacientes con enfermedad aterosclerosa establecida, individuos con alto riesgo cardiovascular y sus familias - EUROACTION PLUS CON INTERVENCIÓN INTENSIVA SOBRE EL TABACO (VARENICLINA)Pacientes fumadores con enfermedad cardiovascular u otra enfermedad aterosclerosa o individuos con riesgo elevado de padecer ECVMedDRA version: 12.1Level: LLTClassification code 10053325Term: Smoking cessation therapyEUCTR2009-012451-18-ESImperial College London696
撤回
4 期
Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain StudyLow Back PainNeuralgiaNCT01298466Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
终止
2 期
Systolic Hypertension in Europe Placebo-Controlled TrialIsolated Systolic HypertensionNCT02088450KU Leuven4,695
已完成
4 期
Euroaction plus intensive smoking intervention (varenicline)prevention of cardiovascular diseasesmoking cessation1008220610003216NL-OMON38232Clinical Research Governance Office,Sir Alexander Fleming Building, Imperial College212
已完成
不适用
istening effort in the European population: A new innovative program of research and training10019243hearing lossHearing impairmentNL-OMON44463Vrije Universiteit Medisch Centrum171